ELITE PHARMACEUTICALS INC /NV/ (ELTP) (CIK 0001053369) (ELTP)
Activity window: Oct. 25, 2025 to Oct. 24, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Apr. 14, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 14, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Elite Pharmaceuticals, Inc.'s Form 10-K for the fiscal year ended March 31, 2025. They remind the company and its management of their responsib… | Read Filing EDGAR |
| Mar. 18, 2026 | CORRESP | Concern from SEC | Moderate | The correspondence from Elite Pharmaceuticals, Inc. to the SEC addresses comments regarding their Form 10-K for the fiscal year ended March 31, 2025. The SEC raised concerns about… | Read Filing EDGAR |
| Mar. 4, 2026 | UPLOAD | Concern from SEC | High | The SEC has issued comments regarding Elite Pharmaceuticals, Inc.'s Form 10-K for the fiscal year ended March 31, 2025, specifically focusing on the company's revenue recognition … | Read Filing EDGAR |